InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: newbieee post# 184560

Tuesday, 07/29/2014 7:14:30 AM

Tuesday, July 29, 2014 7:14:30 AM

Post# of 345849
Read my post again! There is a NOT in the sentence. Liver Sept but 2nd ln NSCLC NOT in sept, hence later in 2015.

Unless you are saying we will not see any early data in 2015 either.
The committee may see the data and STOP the trial early (to allow the control arm patients to get Bavi) if it becomes stat sig. We know it is safe, it was on about 500 patients till now.

The committee doesn't have to way for the interim look-in eventing to occur. We can get stat sig on n=40/40 and proved it in PII 2nd ln NSCLC.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News